"I think you're going to have to readjust the September date for the guesses. If its 20 MACE over 5 months, that's another 7.5 months to 250. Then add 2-3 months for adjudication. So mid-september we might be not much different that we are today, share price wise."

Last dosing and trial completion (whatever that means?) both still listed in the latest BIO CEO presentation as H1 2019. 4.5 months left in H1 2019.......